Blog Posts

Health Center Challenging 340B Patient Definition Responds to HRSA’s and Drug Companies’ Court Arguments

Genesis
Genesis Health Care defended its interpretation of the 340B statute in a filing to the U.S. District Court for the District of South Carolina.
There is no evidence to support federal allegations that a South Carolina community health center illegally diverts 340B-purchased drugs to [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Uncertain Outlook for GOP Drug Shortages Bill with 340B Provisions

Rep. Anna Eshoo, ranking member of the E&C Health Subcommittee, was one of multiple Democrats opposed to a Republican drug shortages bill.
The future of a Republican drug shortages bill with 340B provisions remains unclear after it was examined in a contentious [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Novo Nordisk Providing 340B Refunds on Blockbuster Drug Ozempic

Ozempic package
Drugmaker Novo Nordisk is issuing 340B refunds for certain purchases of its blockbuster diabetes medication Ozempic.
Novo Nordisk will issue refunds to 340B covered entities for some purchases this year of its blockbuster injectable diabetes medication [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

AHIP Objects to Hospital Efforts to Target Medicare Advantage 340B ‘Windfall’

Matthew Eyles
Matthew Eyles, president and CEO of AHIP, objected to hospital-sought rules that target the Medicaid Advantage 340B "windfall."
The largest health insurer advocacy organization urged federal regulators to reject hospital-sought rules to limit the ability of Medicare Advantage [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

News Alert

House Subcommittee Clashes Over 340B Role in Drug Shortages

Rep. Cathy McMorris Rodgers
Legislation sponsored by Rep. Cathy McMorris Rodgers (R-Wash.) was the focus of a partisan clash during a Sept. 14 hearing over changes it would implement for the 340B program.
A House subcommittee hearing today exposed partisan divisions over the 340B program’s impact on generic drug shortages. The Sep. 14 [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Louisiana AG Defends State 340B Contract Pharmacy Law Against Drug Industry Lawsuit

Jeff Landry headshot
Louisiana Attorney General Jeff Landry filed a Sep. 11 response to PhRMA's lawsuit that challenged Louisiana's 340B contract pharmacy law.
The Louisiana attorney general recently asked a federal district judge to dismiss a drug industry lawsuit that challenges Louisiana’s 340B [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

340B Health Centers Appeal Loss in California Medicaid Lawsuit

Michelle Baass headshot
Michelle Baass, director of the California Department of Health Care Services, was the defendant in a California Medicaid lawsuit by health centers.
California health centers that participate in the 340B program recently appealed a federal district judge’s dismissal of a suit to reverse [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Provider POV: 340B is Critical. We Must Raise Our Voices.

SPONSORED CONTENT

For over 35 years, Avita Care Solutions’ Chief Medical Officer, Dr. Christopher Hall, has devoted his career to democratizing and scaling compassionate and competent care initiatives to underserved communities—the very patients the 340B program was designed to help. In the following interview, he offers a provider’s point of view on why the drug discount

Read More »

340B Driving Anti-Competitive Health System Tactics, Says Lawsuit

Jefferson Health building
An independent cancer care practice filed a federal lawsuit against Jefferson Health related to the 340B program.
An independent cancer care practice is suing a Philadelphia health system in federal court over a range of alleged anti-competitive [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Two More Drugmakers Owe 340B Provider Repayments, HRSA Audits Find

HRSA headquarters
A HRSA manufacturer audit found that drugmakers Cencora and Medefil Inc. owe repayments to 340B providers.
Two drugmakers owe repayment to 340B covered entities, according to final audits posted this week by federal officials. American Health [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
×

*Sign up for news summaries and alerts from 340B Report

Site Footer